Cargando…
A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia
Cardiovascular disease (CVD), including heart disease and stroke, continues to be the leading cause of death worldwide. Patients with mental health disorders, including schizophrenia (SCZ) are known to have an increased risk for CVD. Given the association with metabolic syndrome, patients with SCZ a...
Autores principales: | Dao, Joseph, Saran, Savreen, Wang, Melody, Michael, Christina, Phan, Nhu-y, Bellon, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954190/ https://www.ncbi.nlm.nih.gov/pubmed/36831911 http://dx.doi.org/10.3390/brainsci13020368 |
Ejemplares similares
-
Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis
por: Judge, Conor, et al.
Publicado: (2019) -
Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach
por: Bellon, Alfredo, et al.
Publicado: (2021) -
A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?
por: Brotons, Carlos, et al.
Publicado: (2014) -
The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis
por: Abdelmalak, Jonathan, et al.
Publicado: (2023) -
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
por: Rognoni, Carla, et al.
Publicado: (2021)